According to a FDA memo and recent article in the RPM Report, “continuing medical education (CME) has been under attack in Washington in recent years, criticized as representing a way around FDA’s control of medical promotion.” This trend however, is beginning to change. The Food and Drug Administration’s (FDA) is now “turning back to CME […]
